162 related articles for article (PubMed ID: 36177093)
1. Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.
Griveau A; Alnemeh-Al Ali H; Jourdain MA; Dupont A; Eyer J
Int J Pharm X; 2022 Dec; 4():100127. PubMed ID: 36177093
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the self-assembly of the NFL-TBS.40-63 peptide and its interaction with gold nanoparticles as a delivery agent for glioblastoma.
Alnemeh-Al Ali H; Griveau A; Artzner F; Dupont A; Lautram N; Jourdain MA; Eyer J
Int J Pharm X; 2022 Dec; 4():100128. PubMed ID: 36204592
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells.
Griveau A; Arib C; Spadavecchia J; Eyer J
Int J Pharm X; 2022 Dec; 4():100129. PubMed ID: 36164551
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
5. Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptide as a promising drug delivery system.
Jourdain MA; Dupont A; Lautram N; Eyer J
Int J Pharm; 2024 Mar; 652():123805. PubMed ID: 38237710
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
7. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.
Gazaille C; Sicot M; Akiki M; Lautram N; Dupont A; Saulnier P; Eyer J; Bastiat G
Pharm Res; 2021 Apr; 38(4):681-691. PubMed ID: 33829340
[TBL] [Abstract][Full Text] [Related]
9. Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Audrey G; Claire LC; Joel E
Int J Pharm; 2021 Aug; 605():120811. PubMed ID: 34144141
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion.
Carradori D; Labrak Y; Miron VE; Saulnier P; Eyer J; Préat V; des Rieux A
Biomaterials; 2020 Feb; 230():119653. PubMed ID: 31837824
[TBL] [Abstract][Full Text] [Related]
11. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.
Carradori D; Saulnier P; Préat V; des Rieux A; Eyer J
J Control Release; 2016 Sep; 238():253-262. PubMed ID: 27503706
[TBL] [Abstract][Full Text] [Related]
12. The origin of neural stem cells impacts their interactions with targeted-lipid nanocapsules: Potential role of plasma membrane lipid composition and fluidity.
Carradori D; Dos Santos AG; Masquelier J; Paquot A; Saulnier P; Eyer J; Préat V; Muccioli GG; Mingeot-Leclercq MP; des Rieux A
J Control Release; 2018 Dec; 292():248-255. PubMed ID: 30408552
[TBL] [Abstract][Full Text] [Related]
13. The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2013 Oct; 454(2):738-47. PubMed ID: 23603097
[TBL] [Abstract][Full Text] [Related]
14. Cell penetrating peptide (CPP) gold(iii) - complex - bioconjugates: from chemical design to interaction with cancer cells for nanomedicine applications.
Arib C; Griveau A; Eyer J; Spadavecchia J
Nanoscale Adv; 2022 Jul; 4(14):3010-3022. PubMed ID: 36133522
[TBL] [Abstract][Full Text] [Related]
15. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Fressinaud C; Thomas O; Umerska AM; Saulnier P
Neurochem Res; 2020 Nov; 45(11):2732-2748. PubMed ID: 32910302
[TBL] [Abstract][Full Text] [Related]
16. The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2019 Jul; 566():218-228. PubMed ID: 31132447
[TBL] [Abstract][Full Text] [Related]
17. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
[TBL] [Abstract][Full Text] [Related]
18. The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.
Mellinger A; Lubitz LJ; Gazaille C; Leneweit G; Bastiat G; Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2023 Nov; 646():123421. PubMed ID: 37722495
[TBL] [Abstract][Full Text] [Related]
19. Polymer-free hydrogel made of lipid nanocapsules, as a local drug delivery platform.
Pitorre M; Gazaille C; Pham LTT; Frankova K; Béjaud J; Lautram N; Riou J; Perrot R; Geneviève F; Moal V; Benoit JP; Bastiat G
Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112188. PubMed ID: 34082987
[TBL] [Abstract][Full Text] [Related]
20. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
